Michael W. Dunne - Aug 6, 2024 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Director
Signature: /s/ Michael W. Dunne
Stock symbol: ITRM
Transactions as of: Aug 6, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/12/2024, 09:00 AM
Previous filing: Dec 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITRM	Ordinary Shares	Options Exercise		+106K	+93.4%		220K	Aug 6, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Subscription Rights (right to buy)	Options Exercise	$0	-212K	-100%	$0.00^*	0	Aug 6, 2024	Units		$0.61	Direct	F2
transaction	ITRM	Warrants (right to buy)	Options Exercise		+106K			106K	Aug 6, 2024	Ordinary Shares	53.1K	$1.21	Direct	F1
transaction	ITRM	Warrants (right to buy)	Options Exercise		+106K			106K	Aug 6, 2024	Ordinary Shares	106K	$1.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities were purchased in the Issuer's rights offering (the "Offering") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 106,247 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance ("1-year warrants"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance ("5-year warrants").
F2	The Reporting Person validly exercised 212,494 subscription rights to acquire 106,247 units composed of (i) 106,247 ordinary shares, (ii) 106,247 1-year warrants and (iii) 106,247 5-year warrants.

Content

The reported securities were purchased in the Issuer's rights offering (the "Offering") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 106,247 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance ("1-year warrants"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance ("5-year warrants").

The Reporting Person validly exercised 212,494 subscription rights to acquire 106,247 units composed of (i) 106,247 ordinary shares, (ii) 106,247 1-year warrants and (iii) 106,247 5-year warrants.